Prematurely born children have a thicker central macular than children born at term
A recent study featured in the British Journal of Ophthalmology has demonstrated that prematurely born children have a thicker central macular than children born at term.
Professor Gerd Holmström et al., Department of Ophthalmology, University Hospital, Sweden, studied 65 prematurely born children between the ages of 5–16 years and 55 children born at term with Stratus optical coherence tomography (OCT). The foveal minimum, total macular volume and retinal macular thickness in nine macular areas were evaluated.
There was no correlation between macular thickness and refraction or visual acuity. It was found that children with previous retinopathy of prematurity (ROP) had a thicker macular than those who didn't. Children born without ROP still had a thicker macular than the control group. The results revealed that prematurity highly influences central macular thickness and is the most significant risk factor for abnormal foeval development.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
2 Commerce Drive
Cranbury, NJ 08512